Boasting a speaker faculty consisting of over 70% large pharma, alongside leading biotech and consortia, the 5th Liquid Biopsy for Precision Oncology Summit East Coast returns as your definitive forum harnessing the power of liquid biopsies to drive smarter, better and more precise clinical decisions for patients in need. 

Expect to join a wealth of liquid biopsy KOL’s including senior representatives at Bristol Myers Squibb, Pfizer, AstraZeneca and industry-leading diagnostic providers such as Foundation Medicine, Guardant Health, Natera, Personalis, Myriad Genetics, Tempus, Hologic and BioIVT. 

Seize the opportunity to enhance your understanding, gain actionable takeaways and hear directly from senior biopharma experts to develop stronger ctDNA, MRD and next-generation biomarkers and redefine the future of clinical trials for oncology drug development.